Denis Harrington is President, CEO, and Director of FLEX Vascular, the medical device company behind the FLEX Vessel Prep™ System, a technology designed to improve outcomes in vascular interventions. Denis brings more than 30 years of experience in vascular device commercialization and executive leadership. Prior to FLEX, he served as CEO of BridgePoint Medical, guiding the company from development through commercialization and its eventual acquisition by Boston Scientific. He spent 18 years at Boston Scientific, most recently as Senior Vice President of U.S. Cardiology, Rhythm, and Vascular Sales, overseeing more than 1,800 team members and $3 billion in revenue. A graduate of the United States Military Academy at West Point, Denis began his career as an Army officer, a foundation that has shaped his approach to leadership ever since. 

Daniela Blanco is the Co-Founder and CEO of Sunthetics, an AI-driven platform accelerating chemical process development. Trained as a chemical engineer in Venezuela, Daniela grew up surrounded by the oil and chemical industries, which shaped her early understanding of how powerful – yet complex - chemical development can be. She earned her Ph.D. in Chemical Engineering from NYU, where her research centered on redesigning chemical [NB1.1][KD1.2]processes to make them more sustainable. During her doctorate, she began questioning how scientific discoveries actually translate into real-world impact, which led her to NYU’s Entrepreneurial Institute and the formation of Sunthetics after winning the company’s first $100K in funding.

Founder & CEO, Genda